Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Fluorescent protein-scorpion toxin chimera is a convenient molecular tool for studies of potassium channels.
Kuzmenkov AI
,
Nekrasova OV
,
Kudryashova KS
,
Peigneur S
,
Tytgat J
,
Stepanov AV
,
Kirpichnikov MP
,
Grishin EV
,
Feofanov AV
,
Vassilevski AA
.
???displayArticle.abstract???
Ion channels play a central role in a host of physiological and pathological processes and are the second largest target for existing drugs. There is an increasing need for reliable tools to detect and visualize particular ion channels, but existing solutions suffer from a number of limitations such as high price, poor specificity, and complicated protocols. As an alternative, we produced recombinant chimeric constructs (FP-Tx) consisting of fluorescent proteins (FP) fused with potassium channel toxins from scorpion venom (Tx). In particular, we used two FP, eGFP and TagRFP, and two Tx, OSK1 and AgTx2, to create eGFP-OSK1 and RFP-AgTx2. We show that these chimeras largely retain the high affinity of natural toxins and display selectivity to particular ion channel subtypes. FP-Tx are displaced by other potassium channel blockers and can be used as an imaging tool in ion channel ligand screening setups. We believe FP-Tx chimeras represent a new efficient molecular tool for neurobiology.
Figure 1. Molecular model of complex formed between eGFP-OSK1 and KV.FP-Tx modules are colored: eGFP is in green, and OSK1 is in blue; flexible N-terminus and linker are in gray. The functionally crucial lysine residue of Tx is shown in red pointing to the channel selectivity filter. The model was built based on homology with the known structures of eGFP (PDB ID: 2Y0G), OSK1 (1SCO), and complex of the KV1.2-KV2.1 paddle chimera with charybdotoxin (4JTA).
Figure 2. FP-Tx fluorescence and binding to KcsA-KV hybrid channels.(A,D) Fluorescence excitation (dashed lines) and emission (solid lines) spectra of eGFP-OSK1 (A) and RFP-AgTx2 (D). Insets show excitation and emission spectra of separate eGFP and TagRFP. (B,E) Relative binding of eGFP-OSK1 (20 nM) and eGFP (20 nM) (B), and RFP-AgTx2 (10 nM) and RFP (10 nM) (E) to KcsA-KV1.3, KcsA-KV1.1, and KcsA-bearing spheroplasts and to spheroplasts without recombinant channels. (C,F) Typical confocal fluorescence images of KcsA-KV1.3-bearing spheroplasts stained with eGFP-OSK1 (C) and KcsA-KV1.1-bearing spheroplasts stained with RFP-AgTx2 (F). The length of the scale bars is 4 μm for both images.
Figure 3. FP-Tx activity studied by electrophysiology.Shown are representative traces of currents through KV1.1-1.6 channels in control and after application of 1 μM OSK1 (A), and 1 μM eGFP-OSK1 (B), or 0.5 μM AgTx2 (C), and 0.5 μM RFP-AgTx2 (D) (indicated with asterisks).
Figure 4. Concentration-response curves for FP-Tx on KV1 channels.Comparison between OSK1 and eGFP-OSK1 (A), or AgTx2 and RFP-AgTx2 (B).
Figure 5. Binding of FP-Tx to KcsA-KV1-bearing spheroplasts and their displacement by different ligands.(A,D) Saturation curves of eGFP-OSK1 and RFP-AgTx2 binding to KcsA-KV1.1 or KcsA-KV1.3-bearing spheroplasts. (B,C) Competition between eGFP-OSK1 and different ligands for the binding to KcsA-KV1.1 or KcsA-KV1.3-bearing spheroplasts. (E,F) Competition between RFP-AgTx2 and different ligands for the binding to KcsA-KV1.1 or KcsA-KV1.3-bearing spheroplasts. Data of representative experiments are shown. Mean ± S.E. values are presented (number of cells per point, n ≥ 150).
Figure 6. Application of FP-Tx in spheroplast binding assay as a screening tool.(A) Reversibility of eGFP-OSK1 and RFP-AgTx2 binding to KcsA-KV1.3 on spheroplast membrane. The “binding” bar shows signal from spheroplasts incubated with eGFP-OSK1 or RFP-AgTx2 (5.6 nM FP-Tx, 2 h, 37 °C), and the “dissociation” bar shows signal from the same spheroplasts incubated in a ligand-free medium for 4 h for FP-Tx wash-out. (B,C) Influence of potassium channel blockers charybdotoxin (ChTx, 300 nM), kaliotoxin (KTX, 30 nM), scyllatoxin (ScTx, 1 μM), and 4-aminopyridine (4-AP, 10 mM) and crude venoms (38 μg/ml) of M. eupeus, O. scrobiculosus, P. fasciata, and P. murinus on the binding of 5.6 nM eGFP-OSK1 (B) and RFP-AgTx2 (C) to KcsA-KV1.3-bearing spheroplasts. Mean ± S.E. values are shown (n = 3).
Alexander,
The Concise Guide to PHARMACOLOGY 2013/14: ion channels.
2013, Pubmed
Alexander,
The Concise Guide to PHARMACOLOGY 2013/14: ion channels.
2013,
Pubmed
Alexander,
The Concise Guide to PHARMACOLOGY 2013/14: ligand-gated ion channels.
2013,
Pubmed
Ashcroft,
K(ATP) channels and islet hormone secretion: new insights and controversies.
2013,
Pubmed
Baconguis,
Structural plasticity and dynamic selectivity of acid-sensing ion channel-spider toxin complexes.
2012,
Pubmed
Bagal,
Ion channels as therapeutic targets: a drug discovery perspective.
2013,
Pubmed
Banerjee,
Structure of a pore-blocking toxin in complex with a eukaryotic voltage-dependent K(+) channel.
2013,
Pubmed
Beeton,
Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases.
2006,
Pubmed
Bohlen,
A heteromeric Texas coral snake toxin targets acid-sensing ion channels to produce pain.
2011,
Pubmed
,
Xenbase
Catterall,
Neurotoxins that act on voltage-sensitive sodium channels in excitable membranes.
1980,
Pubmed
Catterall,
Voltage-gated ion channels and gating modifier toxins.
2007,
Pubmed
Chen,
X-ray structures of AMPA receptor-cone snail toxin complexes illuminate activation mechanism.
2014,
Pubmed
Chudakov,
Fluorescent proteins and their applications in imaging living cells and tissues.
2010,
Pubmed
Dang,
Total chemical synthesis of biologically active fluorescent dye-labeled Ts1 toxin.
2014,
Pubmed
Dutertre,
Use of venom peptides to probe ion channel structure and function.
2010,
Pubmed
Garcia,
Potassium channels: from scorpion venoms to high-resolution structure.
2001,
Pubmed
Garcia,
Purification and characterization of three inhibitors of voltage-dependent K+ channels from Leiurus quinquestriatus var. hebraeus venom.
1994,
Pubmed
,
Xenbase
Green,
Ion channel assembly: creating structures that function.
1999,
Pubmed
Hoang,
Vietnamese Heterometrus laoticus scorpion venom: evidence for analgesic and anti-inflammatory activity and isolation of new polypeptide toxin acting on Kv1.3 potassium channel.
2014,
Pubmed
Hovius,
Characterization and validation of fluorescent receptor ligands: a case study of the ionotropic serotonin receptor.
2013,
Pubmed
Kirsch,
Segmental exchanges define 4-aminopyridine binding and the inner mouth of K+ pores.
1993,
Pubmed
Kudryashova,
Fluorescent system based on bacterial expression of hybrid KcsA channels designed for Kv1.3 ligand screening and study.
2013,
Pubmed
Kuzmenkov,
Diversity of Potassium Channel Ligands: Focus on Scorpion Toxins.
2015,
Pubmed
Kuzmenkov,
Variability of Potassium Channel Blockers in Mesobuthus eupeus Scorpion Venom with Focus on Kv1.1: AN INTEGRATED TRANSCRIPTOMIC AND PROTEOMIC STUDY.
2015,
Pubmed
,
Xenbase
Mordvintsev,
A model for short alpha-neurotoxin bound to nicotinic acetylcholine receptor from Torpedo californica: comparison with long-chain alpha-neurotoxins and alpha-conotoxins.
2005,
Pubmed
Mouhat,
K+ channel types targeted by synthetic OSK1, a toxin from Orthochirus scrobiculosus scorpion venom.
2005,
Pubmed
O'Brien,
Isolation of acetylcholine receptors.
1972,
Pubmed
Olivera,
Calcium channel diversity and neurotransmitter release: the omega-conotoxins and omega-agatoxins.
1994,
Pubmed
Overington,
How many drug targets are there?
2006,
Pubmed
Peigneur,
A bifunctional sea anemone peptide with Kunitz type protease and potassium channel inhibiting properties.
2011,
Pubmed
,
Xenbase
Pettersen,
UCSF Chimera--a visualization system for exploratory research and analysis.
2004,
Pubmed
Quintero-Hernández,
Scorpion venom components that affect ion-channels function.
2013,
Pubmed
Sali,
Comparative protein modelling by satisfaction of spatial restraints.
1993,
Pubmed
Shakkottai,
Design and characterization of a highly selective peptide inhibitor of the small conductance calcium-activated K+ channel, SkCa2.
2001,
Pubmed
Takacs,
A designer ligand specific for Kv1.3 channels from a scorpion neurotoxin-based library.
2009,
Pubmed
,
Xenbase
Terlau,
Conus venoms: a rich source of novel ion channel-targeted peptides.
2004,
Pubmed
Vandenberg,
hERG K(+) channels: structure, function, and clinical significance.
2012,
Pubmed
Vassilevski,
Molecular diversity of spider venom.
2009,
Pubmed
Wang,
Mapping the receptor site for alpha-scorpion toxins on a Na+ channel voltage sensor.
2011,
Pubmed
Wulff,
Voltage-gated potassium channels as therapeutic targets.
2009,
Pubmed
Yu,
The VGL-chanome: a protein superfamily specialized for electrical signaling and ionic homeostasis.
2004,
Pubmed
Zhang,
Mapping the interaction site for a β-scorpion toxin in the pore module of domain III of voltage-gated Na(+) channels.
2012,
Pubmed